The cerebral vasculature as a therapeutic target for neurological disorders and the role of shear stress in vascular homeostatis and pathophysiology - PubMed (original) (raw)
Review
The cerebral vasculature as a therapeutic target for neurological disorders and the role of shear stress in vascular homeostatis and pathophysiology
Ljiljana Krizanac-Bengez et al. Neurol Res. 2004 Dec.
Abstract
It is widely accepted that vascular mechanisms are involved in the genesis of many neurological disorders. In particular, blood-brain barrier (BBB) dysfunction has been related to the severity of Alzheimer's disease, encephalopathy due to meningitis, multiple sclerosis, HIV-associated encephalopathy, epilepsy, gliomas and metastatic brain tumors. The BBB may constitute an important therapeutic target to protect neurons after CNS diseases. Both in vivo and in vitro, the functional phenotype of vascular endothelium is dynamically responsive to circulating cytokines, growth factors and puslatile blood flow (shear stress). Shear stress can play a critical role in vascular homeostasis and pathophysiology; it is a major regulator of remodeling in developed blood vessels and in blood vessels affected by atherosclerotic lesions. The physiological fluid mechanic stimulus, shear stress, could be considered to be an important 'differentiative' stimulus capable of modulating endothelial phenotype in vivo. Endothelial cells undergo cell cycle arrest after exposure to physiological levels of shear stress. As for mature endothelial cells, in which flow mediated shear stress may play a role in the induction, progression and/or prevention of atherosclerosis by changing their function, stress may play a role in endothelial cell differentiation from hemopoietic stem cells and/or from embryonic stem cells. Stem cells may be used to repair vascular damage, including loss of EC, due to a variety of diseases (e.g. myocardial neovascularization by adult bone marrow derived angioblasts). In the brain, it was proposed that neuron-producing stem cells may be used to treat Alzheimer's disease, paralysis, etc. Surprisingly, very few investigators are exploring the use of endothelial precursors to revert or prevent cerebrovascular disease. This review summarizes the most recent data related to cerebral vasculature as a therapeutic target for neurological disorders and the role of shear stress in blood-brain barrier homeostasis and pathophysiology.
Similar articles
- [Shear stress and vascular formation].
Ando J. Ando J. Nihon Yakurigaku Zasshi. 1996 Mar;107(3):141-52. Nihon Yakurigaku Zasshi. 1996. PMID: 8728287 Review. Japanese. - Flow detection and calcium signalling in vascular endothelial cells.
Ando J, Yamamoto K. Ando J, et al. Cardiovasc Res. 2013 Jul 15;99(2):260-8. doi: 10.1093/cvr/cvt084. Epub 2013 Apr 9. Cardiovasc Res. 2013. PMID: 23572234 Review. - In vivo shear stress response.
Egginton S. Egginton S. Biochem Soc Trans. 2011 Dec;39(6):1633-8. doi: 10.1042/BST20110715. Biochem Soc Trans. 2011. PMID: 22103499 Review. - Vascular mechanobiology: endothelial cell responses to fluid shear stress.
Ando J, Yamamoto K. Ando J, et al. Circ J. 2009 Nov;73(11):1983-92. doi: 10.1253/circj.cj-09-0583. Epub 2009 Oct 5. Circ J. 2009. PMID: 19801852 Review. - Shear stress modulates the expression of thrombospondin-1 and CD36 in endothelial cells in vitro and during shear stress-induced angiogenesis in vivo.
Bongrazio M, Da Silva-Azevedo L, Bergmann EC, Baum O, Hinz B, Pries AR, Zakrzewicz A. Bongrazio M, et al. Int J Immunopathol Pharmacol. 2006 Jan-Mar;19(1):35-48. Int J Immunopathol Pharmacol. 2006. PMID: 16569344
Cited by
- Characterization of individual mouse cerebrospinal fluid proteomes.
Smith JS, Angel TE, Chavkin C, Orton DJ, Moore RJ, Smith RD. Smith JS, et al. Proteomics. 2014 May;14(9):1102-6. doi: 10.1002/pmic.201300241. Epub 2014 Mar 20. Proteomics. 2014. PMID: 24677814 Free PMC article. - Fiber bundle-based integrated platform for wide-field fluorescence imaging and patterned optical stimulation for modulation of vasoconstriction in the deep brain of a living animal.
Kim M, Hong J, Kim J, Shin HJ. Kim M, et al. Biomed Opt Express. 2017 May 1;8(6):2781-2795. doi: 10.1364/BOE.8.002781. eCollection 2017 Jun 1. Biomed Opt Express. 2017. PMID: 28663906 Free PMC article. - Stroke in patients with human immunodeficiency virus infection.
Tipping B, de Villiers L, Wainwright H, Candy S, Bryer A. Tipping B, et al. J Neurol Neurosurg Psychiatry. 2007 Dec;78(12):1320-4. doi: 10.1136/jnnp.2007.116103. Epub 2007 Apr 30. J Neurol Neurosurg Psychiatry. 2007. PMID: 17470469 Free PMC article. - Cytochrome P450 eicosanoids and cerebral vascular function.
Imig JD, Simpkins AN, Renic M, Harder DR. Imig JD, et al. Expert Rev Mol Med. 2011 Mar 1;13:e7. doi: 10.1017/S1462399411001773. Expert Rev Mol Med. 2011. PMID: 21356152 Free PMC article. Review. - Progress and problems in the application of focused ultrasound for blood-brain barrier disruption.
Vykhodtseva N, McDannold N, Hynynen K. Vykhodtseva N, et al. Ultrasonics. 2008 Aug;48(4):279-96. doi: 10.1016/j.ultras.2008.04.004. Epub 2008 Apr 14. Ultrasonics. 2008. PMID: 18511095 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials